Events|

Connect with SHL at BIO International Convention 2017

News Page

SHL is excited to announce our participation as an exhibitor at 2017 BIO International Convention in San Diego, California from June 19-22.

SHL will be at Booth #545 to show a wide range of autoinjectors and pen injectors, including our offerings for low to high volume drug delivery, and our state-of-the-art devices for high viscosity formulations.

The rapid growth of biologics and biosimilars has significantly increased the demand for self-injection devices for the treatment of chronic indications. Biologics are often prescribed to patients with chronic conditions who need frequent injections and are required to self-administer medications at home. With market share for biologic drugs and biosimilar products on the constant rise, SHL develops innovative drug delivery devices focused on patients’ needs.

Boasting over 16,000 participants from across the globe, BIO International Convention is one of the most influential biotech conventions in the world. SHL looks forward to helping the leading biotech and pharma companies meet their clinical and commercial needs with our innovative device designs, as well as world-class device assembly, labeling, and packaging capabilities.

To learn more about our injection devices, visit us at Booth #545 at the San Diego Convention Center.

About SHL

SHL Group is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,000 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

Share:

Related News